BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32758788)

  • 1. Analytical reliability of four oral fluid point-of-collection testing devices for drug detection in drivers.
    Scherer JN; Schuch JB; Rabelo-da-Ponte FD; Silvestrin R; Ornell R; Sousa T; Limberger RP; Pechansky F
    Forensic Sci Int; 2020 Oct; 315():110434. PubMed ID: 32758788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral Fluid Testing for Cocaine: Analytical Evaluation of Two Point-of-Collection Drug Screening Devices.
    Scherer JN; Fiorentin TR; Sousa TRV; Limberger RP; Pechansky F
    J Anal Toxicol; 2017 Jun; 41(5):392-398. PubMed ID: 28334841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. User experience and operational feasibility of four point-of-collection oral fluid drug-testing devices according to Brazilian traffic agents.
    Pechansky F; Scherer JN; Schuch JB; Roglio V; Telles YM; Silvestrin R; Pasa G; Sousa T
    Traffic Inj Prev; 2019; 20(1):30-36. PubMed ID: 30822144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance evaluation of on-site oral fluid drug screening devices in normal police procedure in Germany.
    Musshoff F; Hokamp EG; Bott U; Madea B
    Forensic Sci Int; 2014 May; 238():120-4. PubMed ID: 24699311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicological oral fluid results among Spanish drivers testing positive on on-site drug controls from 2013 to 2015.
    Lema-Atán JÁ; de Castro A; Lendoiro E; López-Rivadulla M; Cruz A
    Drug Alcohol Depend; 2019 Feb; 195():106-113. PubMed ID: 30611978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reliability of point-of-collection testing devices for drugs of abuse in oral fluid: A systematic review and meta-analysis.
    Scherer JN; Fiorentin TR; Borille BT; Pasa G; Sousa TRV; von Diemen L; Limberger RP; Pechansky F
    J Pharm Biomed Anal; 2017 Sep; 143():77-85. PubMed ID: 28577420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of on-site oral fluid screening using Drugwipe-5(+), RapidSTAT and Drug Test 5000 for the detection of drugs of abuse in drivers.
    Wille SM; Samyn N; Ramírez-Fernández Mdel M; De Boeck G
    Forensic Sci Int; 2010 May; 198(1-3):2-6. PubMed ID: 19913376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioids in oral fluid of Spanish drivers.
    Herrera-Gómez F; García-Mingo M; Colás M; González-Luque JC; Álvarez FJ
    Drug Alcohol Depend; 2018 Jun; 187():35-39. PubMed ID: 29626744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of illicit drugs in oral fluid from drivers as biomarker for drugs in blood.
    Gjerde H; Langel K; Favretto D; Verstraete AG
    Forensic Sci Int; 2015 Nov; 256():42-5. PubMed ID: 26295911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral Fluid and Drug Impairment: Pairing Toxicology with Drug Recognition Expert Observations.
    Truver MT; Palmquist KB; Swortwood MJ
    J Anal Toxicol; 2019 Sep; 43(8):637-643. PubMed ID: 31504595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory evaluation and field application of roadside oral fluid collectors and drug testing devices.
    Crouch DJ; Walsh JM; Cangianelli L; Quintela O
    Ther Drug Monit; 2008 Apr; 30(2):188-95. PubMed ID: 18367979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Driving under the influence of drugs -- evaluation of analytical data of drugs in oral fluid, serum and urine, and correlation with impairment symptoms.
    Toennes SW; Kauert GF; Steinmeyer S; Moeller MR
    Forensic Sci Int; 2005 Sep; 152(2-3):149-55. PubMed ID: 15978340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On-site test for cannabinoids in oral fluid.
    Desrosiers NA; Lee D; Schwope DM; Milman G; Barnes AJ; Gorelick DA; Huestis MA
    Clin Chem; 2012 Oct; 58(10):1418-25. PubMed ID: 22912396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of psychoactive substances, alcohol, illicit drugs, and medicines, in Spanish drivers: a roadside study.
    Gómez-Talegón T; Fierro I; González-Luque JC; Colás M; López-Rivadulla M; Javier Álvarez F
    Forensic Sci Int; 2012 Nov; 223(1-3):106-13. PubMed ID: 22947432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and prevalence of drug use in arrested drivers using the Dräger Drug Test 5000 and Affiniton DrugWipe oral fluid drug screening devices.
    Logan BK; Mohr AL; Talpins SK
    J Anal Toxicol; 2014 Sep; 38(7):444-50. PubMed ID: 24894458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A field test of substance use screening devices as part of routine drunk-driving spot detection operating procedures in South Africa.
    Matzopoulos R; Lasarow A; Bowman B
    Accid Anal Prev; 2013 Oct; 59():118-24. PubMed ID: 23770390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of drugs in oral fluid from truck drivers in Brazilian highways.
    Bombana HS; Gjerde H; Dos Santos MF; Jamt REG; Yonamine M; Rohlfs WJC; Muñoz DR; Leyton V
    Forensic Sci Int; 2017 Apr; 273():140-143. PubMed ID: 28273545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Dräger DrugTest 5000 in a Naturalistic Setting.
    Gjerde H; Clausen GB; Andreassen E; Furuhaugen H
    J Anal Toxicol; 2018 May; 42(4):248-254. PubMed ID: 29409046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of selected oral fluid point-of-collection drug-testing devices.
    Crouch DJ; Walsh JM; Flegel R; Cangianelli L; Baudys J; Atkins R
    J Anal Toxicol; 2005; 29(4):244-8. PubMed ID: 15975256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of Δ
    Arkell TR; Kevin RC; Stuart J; Lintzeris N; Haber PS; Ramaekers JG; McGregor IS
    Drug Test Anal; 2019 Oct; 11(10):1486-1497. PubMed ID: 31442003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.